Is Harbin Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Harbin Pharmaceutical pays dividends. Last time was Friday 4th of May 2018 where the investors holding the stock on Friday 4th of May 2018 were paid CNY0.5 per share. Over the last 17 times between 1994 and 2018, Harbin Pharmaceutical has paid CNY4.819999 with an average of CNY0.28 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Harbin Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CNY4.13, you would have made a loss of CNY-1.000 per share or -24.21%
Yes, the average daily trading liquidity for Harbin Pharmaceutical is CNY37.53 million. You should therefore be able to get in and out of your positions relatively fast.
Harbin Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.25, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 2.88%, which is challenging.
We have calculated the inflation risk for Harbin Pharmaceutical to be low [0.5 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.